Immuno-Oncology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase 2, Phase 3, Phase 4) by Design (Interventional Trials, Observational Trials, Expanded Access Trials) by Indication (Solid Tumors, Hematological Cancer, Other Indications) by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Global Industry Assessment (2017 - 2022) & Forecast (2023 - 2030)

Includes

• Report accessible by 1 user only
• Free 15% or 20 hours of customisation
• Free post-sale service assistance
• Direct access to lead analysts on mail
• Report delivery on PDF & Excel
• Report Coverage: Global
• Free Post-Sale Service Assistance